Abstract
This pilot study explored associations between gamma-aminobutyric acid (GABA) spectroscopy and functional magnetic resonance imaging in transgender women with depression. Twenty participants completed mental health surveys and imaging between January and March 2024. Depression severity was measured by Patient Health Questionnaire-9 (PHQ-9) scores. Higher PHQ-9 scores were associated with lower GABA levels in the hippocampus and lower fractional amplitude of low-frequency fluctuations (fALFF) in the dorsolateral prefrontal cortex. These findings revealed interactions between neurotransmitter signaling and functional brain activity of the hippocampal-prefrontal circuit in depression. Future large-scale neuroimaging studies are needed.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by Advance Diagnostic Imaging Center Fund (No. 32080009), and Faculty of Medicine Ramathibodi Hospital (No. RF_66138), Mahidol University, Thailand. Setthanan Jarukasemkit is supported by the Prince Mahidol Award Youth Program, Prince Mahidol Award Foundation under the Royal Patronage.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Human Research Ethics Committee of Faculty of Medicine Ramathibodi Hospital, Mahidol University, gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* joint last authors.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
